NCT07450209

Brief Summary

This 2-arm clustered, randomized community trial will test a multilevel, religiously-tailored COVID-19 rapid, self-testing and treatment intervention against a nontailored, education condition on uptake of COVID-19 rapid testing with 900 adult African American church members and community members using outreach ministry services from 12 churches at 6 months. Rapid COVID-19 self-testing and contact tracing (beliefs and practices), and use of linkage to care services (e.g., referrals to treatment, health insurance, medical home/appointments, community resources) will also be examined. Findings from this study could provide a scalable model for feasible, accessible and acceptable COVID-19 rapid, self-testing (with rapid linkage to treatment and health/community resources) in public (churches and their affiliate settings and organizations), home, and health provider spaces by equipping African American churches with culturally-appropriate, easy-to-use rapid test kits, health department support, and tailored COVID-19 test-to-treat education and promotion tools.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
900

participants targeted

Target at P75+ for phase_2

Timeline
Completed

Started May 2024

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 15, 2024

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

February 24, 2026

Completed
5 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 4, 2026

Completed
Last Updated

March 4, 2026

Status Verified

February 1, 2026

Enrollment Period

1.8 years

First QC Date

February 24, 2026

Last Update Submit

February 26, 2026

Conditions

Keywords

COVID-19 testing, faith-based organizations, COVID-19 treatment, community engagement

Outcome Measures

Primary Outcomes (1)

  • Uptake of COVID-19 testing

    COVID19 rapid testing will be assessed via self-report (ever, last 6 months, month/day/year) and objectively assessed with data reports provided by the Kansas City MO Health Department

    Baseline, 6 months

Study Arms (2)

COVID-19 rapid test-to-treat

EXPERIMENTAL

Church-based COVID19 rapid testing (2 testing events) promoted with a COVID19 Toolkit delivered by church health workers and linkage to treatment/care delivered by contact tracer community health workers.

Behavioral: COVID-19 rapid test-to-treatBehavioral: Standard COVID19 education control arm

Standard COVID-19 education control arm

ACTIVE COMPARATOR

Standard COVID-19 information inclusive of test-to-treat information that has not been tailored will be delivered by church health workers

Behavioral: Standard COVID19 education control arm

Interventions

This community-engaged approach includes trained church leaders delivering a culturally, church-appropriate COVID-19 test-to-treat toolkit materials/activities via multilevel church outlets: a) self-help materials and tailored text messages; b) ministry group educational information; c) church services with COVID-19 related materials/activities (e.g., sermons, pastors modeling rapid-self testing, testimonials, bulletins); and d) church-community level linkage to care services (e.g., healthcare, community resources) provided by health department testers cross-trained as community health workers. Intervention churches will host 2 COVID-19 TTT events in coordination with the local health department, which provide rapid testing onsite at participating churches, provide members with take-home COVID-19 rapid self-test kits, and support an option for members to use a proctored telehealth rapid test that will be able to qualify persons for a anti-viral treatment prescription (e.g., Paxlovid).

COVID-19 rapid test-to-treat

Multilevel delivery of standard COVID-19 education by church leaders and 2 COVID-19 testing events.

COVID-19 rapid test-to-treatStandard COVID-19 education control arm

Eligibility Criteria

Age18 Years - 120 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • a) self-identify as African American, b) aged 18 or older; c) willing to participate in 2 surveys after church services, electronically, by phone, or in the study's office space; d) willing to provide contact information (i.e., two phone numbers, mailing/email address, phone numbers for two persons with whom they have ongoing contact; and e) regularly attend church (\>once a month) or use church outreach services (e.g., daycare services, food programs) \>4 times/year.

You may not qualify if:

  • persons with plans to move from KC metro area over the next 12 months and non-English speaking/reading persons.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

School of Medicine

Kansas City, Missouri, 64108, United States

Location

Study Officials

  • Jannette Berkley-Patton, PhD

    University of Missouri, Kansas City

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
SCREENING
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 24, 2026

First Posted

March 4, 2026

Study Start

May 15, 2024

Primary Completion

March 1, 2026

Study Completion

March 1, 2026

Last Updated

March 4, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations